Digital Therapeutics Alliance (DTA) is expanding efforts in the Asia-Pacific region to shape regulatory landscapes and develop scalable market access pathways for digital therapeutic products and other digital health technologies.
By becoming an APAC member of DTA, you can learn about current best practices, engage with industry leaders, collaborate with fellow DTx companies, participate in member events, and help shape the DTx industry in the APAC region by contributing your expertise.
The Value of DTA’s APAC Membership
- Policy and Advocacy: Take part in establishing regulatory processes and payment channels to expand patient access.
- Commercialization: Help drive DTx product development, adoption, and integration to transform healthcare (e.g., through a product launch playbook).
- Education: Prioritize the patient and clinician experience in the development and delivery of safe, effective, and equitable DTx products. This involves payor and clinician education, as well as patient engagement.
- Community Building and Engagement: Connect with like-minded industry leaders and stakeholders within the Asia Pacific digital health community. Foster collaborations, share insights, and participate in discussions that drive the industry forward.
What is included in APAC Membership?
- Participation in DTA’s Monthly APAC Task Group Meeting
- Access to DTA’s APAC Slack Channel
- Access to DTA’s WeChat Group
- Participation in DTA’s APAC Member Events
- Receiving Monthly APAC Newsletters
Meet Roberta Sarno, DTA’s Head of APAC Policy!
Roberta is a global health advisor passionate about tackling the most pressing health challenges through collaboration. With 14 years of experience in the healthcare sector across APAC, Europe, and the US, she has played pivotal roles in shaping digital health education and policies in the Asia-Pacific. She worked as the digital health director at the Asia Pacific Medical Technology Association (APACMed) in Singapore, senior consultant and business development manager at Alcimed in Paris, and genetic engineering researcher at the Curie Institute in Paris. Roberta holds a PhD in Genetics from the Sorbonne University of Paris, a business background from INSEAD, and is currently pursuing a master’s in Global Health Policy at the London School of Hygiene & Tropical Medicine. Her expertise spans digital health, health technologies, global health policy, infectious disease control, non-communicable disease management, and health systems strengthening. She currently resides in Doha, Qatar.
“DTA’s the leader and go-to resource for all things digital therapeutics worldwide. By promoting the understanding, adoption, and integration of clinically evaluated digital therapeutics, DTA is critical in advancing this industry and making these innovative treatments more widely accessible. This aligns perfectly with our mission at WELT.”
Danny Jooyoung Kim, Head of WELT USA
Contact Hazel Nugent (hazel@dtxalliance.org) for more information about DTA’s APAC Membership today!
Complete your application today!